Disclaimer: This content is for informational and educational purposes only and should not be construed as financial or investment advice. Always do your own research and consult a licensed financial advisor before making investment decisions.

Disclosure: The author does not hold a position in NNOX.

← Back to Free Index

NNOX

Analysis as of: 2026-06-07

Nano-X Imaging Ltd.

Nanox develops digital tomosynthesis imaging systems and sells related AI, cloud, remote-reading, and health IT solutions to healthcare providers.

ai cloud healthcare medical devices software

On Yahoo Finance ...

Jump to: Summary • Analysis • Opportunity • Risk • Trends • LE Structure • Third Party Analyst Consensus

Summary

Proof of Activations Matters More Than Announced Deals

Low-cost 3D imaging plus attached software offers real upside if signed channels turn into active sites. The gating issue is whether financing and deployments arrive fast enough to convert promise into recurring revenue.

Analysis

Thesis

This is a distressed but real option on proving that low-cost 3D imaging hardware can become a recurring imaging utility; if financing, activations, and software attachment line up, revenue can scale far faster than today’s valuation implies.

Last Economy Alignment

Regulated hardware and workflow embedding protect Nanox more than pure imaging software, but value capture still depends on funding, approvals, and site deployment rather than AI alone.

Upgrade to Allocator to also access: Thesis Critique

Opportunity Outlook

Average Implied 5-Year Multiple

8.3x (from 5 most recent analyses)

Reasoning

The rerating case is driven by proving that each deployed system becomes a recurring revenue node, not by shipping boxes alone. If Nanox clears the funding overhang and turns recent channel wins into live, utilized sites, investors can underwrite a broader imaging stack with higher-quality revenue. I still cap the multiple because the model remains hardware-linked, approval-gated, and likely dilution-bearing.

Upgrade to Allocator to also access: Simplified Opportunity Explanation

Risk Assessment

Overall Risk Summary

This is a sequence-risk story: extend runway, ship systems, activate sites, and then prove each site carries attractive recurring mix. The upside is large because the base is tiny and the product is cleared, but missing any step can force more dilution before the flywheel forms.

Upgrade to Allocator to also access: Tech Maturity Risk Score, Adoption Timing Risk Score, Moat Strength Risk Score, Capital Needs Risk Score, Regulatory Risk Score, Execution Risk Score, Concentration Risk Score, Unit Economics Risk Score, Valuation Risk Score, Macro Sensitivity Risk Score

Trends

Key Changes

June 2 brought a Peru distribution agreement with an initial six-system pilot, adding new geographic option value but no near-term proof of utilization yet.
No financing or liquidity-extension filing appeared in the last week, so the main survival and dilution overhang is still unresolved.
There has still been no fresh disclosure of meaningful live U.S. commercial activations, so signed-channel momentum remains ahead of hard revenue proof.

Forecast update

I now haircut upside more for equity leakage and for the gap between signed agreements and revenue-producing installs, so value creation looks meaningful but less explosive to common shareholders.

Upgrade to Builder to also access: Future Considerations

Last Economy Structure

AI Industrial Score

0.25

The business could win because it controls a regulated imaging device and can attach cloud, AI, and reading services each time a site goes live. But it does not control the core AI stack, and the whole flywheel stalls if funding, permits, and installations stay slow.

Upgrade to Reader to also access: Score Decomposition, Confidence Level

Upgrade to Allocator to also access: Obsolescence Vectors, Pricing Fragility

Upgrade to Reader to also access: Constraint Benefit Score, Obsolescence Risk Score

Third Party Analyst Consensus

12-Month Price Target

$6.00

Upgrade to Reader to also access: Bull Case, Base Case, Bear Case

Next Arc Research